Intel stock spikes after report of possible US government stake
Investing.com - Oscar Health (NYSE: OSCR) reported second quarter EPS of $0.20, $0.04 better than the analyst estimate of $0.16. Revenue for the quarter came in at $2.22B versus the consensus estimate of $2.21B.
Guidance
Oscar Health sees FY 2024 revenue of $9.00B-$9.10B versus the analyst consensus of $8.60B.
Oscar Health's stock price closed at $17.23. It is down -20.38% in the last 3 months and up 141.65% in the last 12 months.
Oscar Health saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Oscar Health's stock price’s past reactions to earnings here.
According to InvestingPro, Oscar Health's Financial Health score is "good performance".
Check out Oscar Health's recent earnings performance, and Oscar Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar